Evidence map›Paper›PMID 40385053›Full record

ReviewAmerican journal of translational research2025

Nicotine replacement therapy: insights into the mechanisms and potential of nicotine receptor pathway.

Nishant Patidar, Archana M Navale, Nitesh Parsaila, Dinesh Sharma, Prachi Nahar, Sagar Shinde, Nilay Solanki, Ajay Shelke

Abstract readReview
In one paragraph

Review in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nishant PatidarDepartment of Pharmacology, Parul Institute of Pharmacy, Parul University Limda, Vadodara, Gujarat, India.
Archana M NavaleDepartment of Pharmacology, Parul Institute of Pharmacy, Parul University Limda, Vadodara, Gujarat, India.
Nitesh ParsailaDepartment of Pharmacology, Parul Institute of Pharmacy, Parul University Limda, Vadodara, Gujarat, India.
Dinesh SharmaDepartment of Pharmacology, Parul Institute of Pharmacy, Parul University Limda, Vadodara, Gujarat, India.
Prachi NaharDepartment of Pharmacology, Parul Institute of Pharmacy, Parul University Limda, Vadodara, Gujarat, India.
Sagar ShindeDepartment of Pharmacology, Parul Institute of Pharmacy, Parul University Limda, Vadodara, Gujarat, India.
Nilay SolankiDepartment of Pharmacology, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology Changa, Gujarat, India.
Ajay ShelkeDepartment of Pharmacology, Parul Institute of Pharmacy, Parul University Limda, Vadodara, Gujarat, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nicotine addiction is a complex phenomenon entwined with intricate mechanisms within the nicotine receptor pathway. This review offers an insightful exploration of this multifaceted landscape, delving into the interplay between nicotinic acetylcholine receptors (nAChRs) and their pivotal role in neurotransmission. The structural and functional aspects of nAChRs, their distribution within the peripheral and central nervous systems, and their involvement in modulating diverse signalling cascades are reviewed. The clinical implications of nicotine addiction and the challenges in smoking cessation are also explored. Nicotine Replacement Therapy (NRT) drugs, designed to alleviate withdrawal symptoms and aid in smoking cessation, are critically evaluated. This article synthesizes current research findings on the efficacy, safety, and limitations of various NRT modalities. Furthermore, emerging pharmacotherapeutic strategies and novel molecules aimed at optimizing NRT outcomes are discussed. The potential of leveraging a deeper understanding of the nicotine receptor pathway to develop more targeted and efficacious NRT interventions is emphasized. The exploration of adjunct therapies and combination approaches to enhance the success rates of smoking cessation is also addressed. Through a synthesis of preclinical and clinical evidence, this article aims to provide a comprehensive resource for researchers, clinicians, and policymakers working towards advancing the field of nicotine addiction treatment. As the global effort to combat tobacco-related health challenges intensifies, a nuanced understanding of the nicotine receptor pathway and its therapeutic implications becomes increasingly imperative.

Indexed as

bupropionCB1 receptor antagonistCRF1 receptor pathwayneuropharmacologyreward pathwayvarenicline

Identifiers

PMID40385053
PMCPMC12082489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.